Joe DePinto, MBA, head of cell, gene and advanced therapies at McKesson , met with MHE at the annual Asembia Specialty ...

Joe DePinto from McKesson discussed the challenges facing cell and gene therapies, particularly around reimbursement, and ...

As healthcare AI evolves, there will be a greater emphasis on streamlining administrative tasks, drug production and service ...

At this year’s Asembia conference in Las Vegas, Shawn Griffin, M.D., president and CEO of URAC, spoke about the need for ...

Healthcare hasn't been a priority of the second Trump administration so far, panelists at the Asembia agreed. Medicaid may ...

Insurance hurdles and the complexities of prior authorization create barriers to care, according to oncologists in a new ...

The margins are small, and the services they provide must be “high touch.” 340B participation and cost-plus pricing are ...

Novo Nordisk has teamed up with Hims & Hers Health, LifeMD and Ro for cash-paying patients to access Wegovy injection 2.4 mg ...

Shawn Griffin, M.D., president and CEO of URAC, shared his insights into best practices for promoting health equity during ...

Managed Healthcare Executive asked several experts in healthcare and managed care to share the trends they think the industry ...

A future where healthcare may include augmented reality, robots and drones may be more fact than fiction, says George Van Antwerp, SVP of product innovation and strategic planning at Prime ...